Beximco Pharmaceuticals Limited (BST:R2WA)

Beximco Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 24, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	329	418	550	706	786	294
Market Cap Growth	-45.37%	-23.94%	-22.07%	-10.21%	167.81%	-16.61%
Enterprise Value	380	495	669	861	868	406
Last Close Price	0.42	0.42	0.37	0.99	0.87	0.31
PE Ratio	6.43	9.04	14.14	13.46	15.43	7.99
PS Ratio	0.88	1.19	1.66	1.99	2.68	1.10
PB Ratio	0.76	1.01	1.37	1.55	2.12	0.86
P/TBV Ratio	0.92	1.24	1.70	1.96	2.25	0.92
P/FCF Ratio	-	8.27	17.75	28.75	22.58	8.51
P/OCF Ratio	-	6.30	10.72	13.23	13.13	5.06
EV/Sales Ratio	1.18	1.40	2.02	2.43	2.96	1.52
EV/EBITDA Ratio	5.14	6.25	8.84	10.20	11.70	5.98
EV/EBIT Ratio	6.20	7.52	11.48	12.78	13.75	7.22
EV/FCF Ratio	11.51	9.78	21.57	35.06	24.92	11.76
Debt / Equity Ratio	0.12	0.12	0.22	0.28	0.20	0.32
Debt / EBITDA Ratio	0.58	0.60	1.18	1.50	1.02	1.62
Debt / FCF Ratio	1.51	0.95	2.89	5.16	2.18	3.18
Asset Turnover	0.64	0.64	0.58	0.59	0.58	0.52
Inventory Turnover	1.77	1.87	1.77	1.91	2.03	1.91
Quick Ratio	0.60	0.52	0.37	0.35	0.39	0.35
Current Ratio	2.13	2.18	1.57	1.45	1.47	1.15
Return on Equity (ROE)	12.45%	11.79%	9.81%	12.19%	14.72%	11.31%
Return on Assets (ROA)	7.62%	7.48%	6.38%	6.95%	7.75%	6.76%
Return on Capital (ROIC)	9.45%	8.92%	7.49%	8.06%	8.98%	7.75%
Return on Capital Employed (ROCE)	14.10%	13.90%	12.30%	12.30%	14.80%	13.90%
Earnings Yield	15.56%	11.06%	7.07%	7.43%	6.48%	12.52%
FCF Yield	10.03%	12.09%	5.63%	3.48%	4.43%	11.76%
Dividend Yield	5.91%	7.60%	7.89%	3.62%	4.02%	4.61%
Payout Ratio	24.96%	27.21%	33.98%	31.68%	11.28%	17.13%
Total Shareholder Return	5.91%	7.60%	7.89%	3.62%	4.02%	4.61%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.